FR2356424A1 - Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales - Google Patents

Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales

Info

Publication number
FR2356424A1
FR2356424A1 FR7720100A FR7720100A FR2356424A1 FR 2356424 A1 FR2356424 A1 FR 2356424A1 FR 7720100 A FR7720100 A FR 7720100A FR 7720100 A FR7720100 A FR 7720100A FR 2356424 A1 FR2356424 A1 FR 2356424A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
phophonoformic
viral infections
compositions based
fight against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7720100A
Other languages
English (en)
Other versions
FR2356424B1 (fr
Inventor
Bertil Franck Harald Eriksson
Ake John Erik Helgstrand
Alfons Misiorny
Goran Bertil Stening
Stig-Ake Alfred Stridh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2356424(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of FR2356424A1 publication Critical patent/FR2356424A1/fr
Application granted granted Critical
Publication of FR2356424B1 publication Critical patent/FR2356424B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques contenant, à titre d'ingrédient actif, une quantité efficace d'un composé de formule :
FR7720100A 1976-07-01 1977-06-30 Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales Granted FR2356424A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (2)

Publication Number Publication Date
FR2356424A1 true FR2356424A1 (fr) 1978-01-27
FR2356424B1 FR2356424B1 (fr) 1980-04-18

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720100A Granted FR2356424A1 (fr) 1976-07-01 1977-06-30 Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales

Country Status (22)

Country Link
US (4) US4215113A (fr)
JP (1) JPS536428A (fr)
AT (1) AT369014B (fr)
AU (1) AU510809B2 (fr)
BE (1) BE856355A (fr)
BG (1) BG60834B2 (fr)
CA (1) CA1077848A (fr)
CH (1) CH641471A5 (fr)
DE (1) DE2728685C2 (fr)
DK (1) DK288877A (fr)
FI (1) FI772030A (fr)
FR (1) FR2356424A1 (fr)
GB (1) GB1585615A (fr)
HK (1) HK28984A (fr)
IE (1) IE45753B1 (fr)
LU (2) LU77666A1 (fr)
MX (1) MX9203635A (fr)
MY (1) MY8500125A (fr)
NL (2) NL180068C (fr)
NO (1) NO772299L (fr)
SE (1) SE7607496L (fr)
SG (1) SG80383G (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003008A1 (fr) * 1977-12-22 1979-07-11 Astra Läkemedel Aktiebolag Dérivés de carbamoylphosphonates, préparations pharmaceutiques et leur utilisation contre les virus
EP0831842A1 (fr) * 1995-06-06 1998-04-01 University Of Southern California Procedes et compositions servant a inhiber la replication du cytomegalovirus

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (fr) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Substances pharmaceutiques obtenues a partir de derives d'acide hydroxycarbonylphosphonique
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
EP0101441B1 (fr) * 1982-02-12 1987-01-14 Syntex (U.S.A.) Inc. Compositions anti-virales
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
AU5014285A (en) * 1985-10-21 1987-05-05 Sergio, W. Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
US20060166941A1 (en) * 2003-03-14 2006-07-27 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
WO2006119174A1 (fr) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Methode de traitement oculaire de demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US9006219B2 (en) 2008-03-12 2015-04-14 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (fr) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Formes galéniques transmucosales du foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003008A1 (fr) * 1977-12-22 1979-07-11 Astra Läkemedel Aktiebolag Dérivés de carbamoylphosphonates, préparations pharmaceutiques et leur utilisation contre les virus
EP0831842A1 (fr) * 1995-06-06 1998-04-01 University Of Southern California Procedes et compositions servant a inhiber la replication du cytomegalovirus
EP0831842A4 (fr) * 1995-06-06 1998-08-19 Univ Southern California Procedes et compositions servant a inhiber la replication du cytomegalovirus

Also Published As

Publication number Publication date
US4339445A (en) 1982-07-13
MY8500125A (en) 1985-12-31
BG60834B2 (bg) 1996-04-30
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
DK288877A (da) 1978-01-02
CA1077848A (fr) 1980-05-20
NL180068B (nl) 1986-08-01
FR2356424B1 (fr) 1980-04-18
US4665062A (en) 1987-05-12
LU88310I2 (fr) 1994-05-04
US4215113A (en) 1980-07-29
DE2728685C2 (de) 1982-09-16
NL180068C (nl) 1987-01-02
AU510809B2 (en) 1980-07-17
ATA465477A (de) 1982-04-15
AU2650577A (en) 1979-01-04
SG80383G (en) 1984-08-03
IE45753B1 (en) 1982-11-17
NL930053I1 (nl) 1993-09-01
LU77666A1 (fr) 1977-10-07
FI772030A (fr) 1978-01-02
US4771041A (en) 1988-09-13
NO772299L (no) 1978-04-25
CH641471A5 (de) 1984-02-29
NL930053I2 (nl) 1994-01-03
MX9203635A (es) 1992-09-01
BE856355A (fr) 1978-01-02
JPS536428A (en) 1978-01-20
AT369014B (de) 1982-11-25
NL7707235A (nl) 1978-01-03
SE7607496L (sv) 1978-01-02
DE2728685A1 (de) 1978-01-12
GB1585615A (en) 1981-03-11
JPS562046B2 (fr) 1981-01-17

Similar Documents

Publication Publication Date Title
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
FR2372624A1 (fr) Mercaptoacylamino-acides et leur utilisation pour soulager l'hypertension due a l'angiotensine
FR2371454A1 (fr) Nouvelles compositions pharmaceutiques a base d'alcaloides peptidiques de l'ergot de seigle
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2418214A1 (fr) Compose de formule 1-(2',6',6'-trimethylcyclohexyl)-hexane-3-ol utilise notamment comme fixateur pour compositions de parfums
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
DK607783A (da) Nitroaliphatiske forbindelser
FR2374903A1 (fr) Nouvelle association utilisable en medecine veterinaire
FR2374039A1 (fr) Compositions contenant un derive de l'acide salicylique et applications a titre de medicament
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
FR2381034A1 (fr) Compositions pharmaceutiques analgesiques et anti-inflammatoires a base de 1,3,5-triazine
HUP9601526A2 (hu) Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
JPS5735515A (en) Immunoregulating agent
FR2419675A1 (fr) Compositions fongicides a base de phosphites d'isothiouronium
FR2430230A1 (fr) Medicaments a base de derives de l'acide anthranilique
FI862636A0 (fi) Farmaceutiska kompositoner med neuroleptisk effekt och foerfarande foer deras framstaellning.
FR2354762A1 (fr) Produits et compositions pour lutter contre l'alcoolisme
SE8702422D0 (sv) Improvements in or relating to fungicides
DK601483D0 (da) Benzhydrylpiperazinderivater
FR2363560A1 (fr) Nouveau compose a action analgesique et compositions therapeutiques en contenant
FR2444462A1 (fr) Compositions pour controler l'hypertension et les troubles intestinaux comprenant un derive de n-aryl n'2-(imidazolidinylidene)-uree
JPS5634625A (en) Antitumorigenic agent

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: FOSCARNET SODIUM HEXAHYDRATE; NAT. REGISTRATION NO/DATE: NL 17545 19910412; FIRST REGISTRATION: DK - 6705 19890303

Spc suppl protection certif: 93C0016

Filing date: 19930611

CP Supplementary protection certificate (spc) filed

Free format text: 93C0016, 930611

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 93C0016, 930611

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 93C0016, 930611, EXPIRES:20020629